In vivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI

Magnetic Resonance Imaging

Volumn 14, Issue 4, 1996, Pages 391-402

  Tiefenauer, Louis X ^a   Tschirky, A ^a   Kuhne G ^a   Andres, R Y ^a  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

Antibody; Biodistribution; Magnetite nanoparticles; MRI; Tumor targeting

Indexed keywords

ALBUMIN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; CONTRAST MEDIUM; GLYCOPHORIN B; MACROGOL; MAGNETITE; NANOPARTICLE; SIALOPROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CARCINOMA; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG TARGETING; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALIA; MUS MUSCULUS;

EID: 0029883393     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0730-725X(95)02106-4     Document Type: Article

References (42)

1. Fahlvik, A.K.; Klaveness, J.; Stark, D.D. Iron oxides as MR imaging contrast agents. J. Magn. Reson. Imaging 3:187-194; 1993.
2. Saini, S.; Stark, D.D.; Hahn, P.F.; Wittenberg, J.; Brady, T.J.; Ferrucci, J.T. Ferrite particles: A superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology 162:211-216; 1987.
3. Pouliquen, D.; Le Jeune, J.J.; Perdrisot, R.; Ermias, A.; Jallet, P. Iron oxide nanoparticles for use as an MRI contrast agent: Phamacokinetics and metabolism. Magn. Reson. Imaging 9:275-283; 1991.
4. Senéterre, E.; Weissleder, R.; Jaramillo, D.; Reimer, P.; Lee, A.S.; Brady, T.J.; Wittenberg, J. Bone marrow: Ultrasmall superparamagnetic iron oxid MR imaging. Radiology 179:529-533; 1991.
5. 2 relaxation effects. Magn. Reson. Imaging 11:219-228; 1993.
6. Bengele, H.H.; Palmacci, S.; Rogers, J.; Jung, C.W.; Crenshaw, J.; Josephson, L. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration. Magn. Reson. Imaging 12:433-442; 1994.
7. Josephson, L.; Groman, E.V.; Menz, E.; Lewis, J.M.; Bengele, H. A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent. Magn. Reson. Imaging 8:637-646; 1990.
8. Schaffer, B.K.; Linker, C.; Papisov, M.; Tsai, E.; Nossiff, N.; Shibata, T.; Bogdanov, A.; Brady, T.J., Weissleder, R. MION-ASF: Biokinetics of an MR receptor agent. Magn. Reson. Imaging 11:411-417; 1993.
9. Weissleder, R.; Lee, A.S.; Fischmann, A.J.; Reimer, P.; Shen, T.; Wilkinson, R.; Callahan, R.J.; Brady, T.J. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: Antibody MR imaging. Radiology 181:245-249; 1991.
10. Reimer, P.; Weissleder, R.; Lee, A.S.; Buettner, S.; Wittenberg, J.; Brady, T.J. Asialoglycoprotein receptor function in benign liver disease: Evaluation with MR imaging. Radiology 178:769-774; 1991.
11. Weissleder, R.; Lee, A.S.; Khaw, B.A.; Shen, T.; Brady, T.J. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology 182:381-385; 1992.
12. Bulte, J.W.M.; Hoeckstra, Y.; Kamman, R.L.; Magin, R.L.; Webb, A.G.; Briggs, R.W.; Go, K.G,.; Hulstaert, C.E.; Miltenyi, S.; The, T.H.; De Leij, L. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn. Reson. Med. 25:148-157; 1992.
13. Cerdan, S.; Lötscher, H.R.; Künnecke, B.; Seelig, J. Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors. Magn. Reson. Med. 12:151-163; 1989.
14. Pouliquen, D.; Perdrisot, R.; Ermias, A.; Akoka, S.; Jallet, P.; Le Jeune, J.J. Superparamagnetic iron oxide nanoparticles as a liver MRI contrast agent: Contribution of microencapsulation to improved biodistribution. Magn. Reson. Imaging 7:619-627; 1989.
15. Shen, T.; Weissleder, R.; Papisov, M.; Bogdanov, A.; Brady, T.J. Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties. Magn. Reson. Med. 29:599-604; 1993.
16. Bulte, J.W.M.; Ma, L.D.; Magin, R.L.; Kamman, R.L.; Hulstraert, C.E.; Go, K.G.; The, T.H.; de Leij, L. Selective MR imaging of labeled human peripheral blood mononuclear cells by liposomes mediated incorporation of dextran-magnetite particles. Magn. Reson. Med. 29:32-37; 1993.
17. Bulte, J.W.M.; Douglas, T.; Mann, S.; Frankel, R.B.; Moskowitz, B.M.; Brooks, R.A.; Baumgarner, C.D.; Vymazal, J.; Strub, M.-P.; Frank, J.A. Magnetoferritin: Characterization of a novel superparamagnetic MR contrast agent. J. Magn. Reson. Imaging 4:497-505; 1994.
18. Tiefenauer, L.X.; Kühne, G.; Andres, R.Y. Antibody-magnetite nanoparticles: In vivo characterization of a potential tumor-specific contrast agent for magnetic resonance imaging. Bioconjug. Chem. 4:347-352; 1993.
19. 2-relaxivity. In: Book of abstracts: Eleventh Annual Meeting of the Society of Magnetic Resonance in Medicine. Berlin:SMRM; 1992: p. 1415.
20. Tiefenauer, L.; Hintermann, T. Oriented immobilization of antibody molecules to magnetite particles used as a target specific contrast agent in MRI. In: Book of abstracts: 22nd Meeting of the Federation of European Biochemical Societies (FEBS). Stockholm. 1993:C25-307.
21. Senior, J.; Delgado, C.; Fisher, D.; Tilock, C.; Gregoriadis, G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: Studies with poly(ethylenceglycol)-coated vesicles. Biochem. Biophys. Acta 1062:77-82; 1991.
22. Allen, T.M.; Hansen, C.; Martin, F.; Redemann, C.; Yau-Young, A. Liposomes containing synthetic lipid derivatives of poly (ethyleneglycol) show prolonged circulation half-lives in vivo. Biochem. Biophys. Acta 1066:29-36; 1991.
23. Gref, R.; Minamitake, Y.; Peracchia, M.T.; Trubetskoy, V.; Torchilin, V.; Langer, R. Biodegradable long-circulating polymeric nanospheres. Science 263:1600-1603; 1994.
24. 1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett. 284:263-266; 1991.
25. Klibanov, A.L.; Maruyama, K.; Torchilin, V.P.; Huang, L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:235-237; 1990.
26. Gabizon, A.; Papahadjopoulos, D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 85:6949-6953; 1988.
27. Maruyama, K.; Kennel, S.J.; Huang, L. Lipid composition is important for highly efficient target binding and retention of immunoliposomes. Proc. Natl. Acad. Sci. USA 87:5744-5748; 1990.
28. Hilkens, J.; Ligtenberg, M.J.L.; Vos, H.L.; Litvinov, S.V. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem. Sci. 17: 359-363; 1992.
29. 1 on liposome circulation time: Evidence supporting the dysopsin hypothesis. Biochem. Biophys. Acta 1166:105-114; 1993.
30. Wassef, N.M.; Matyas, G.R.; Alving, C.R. Complement-dependent phagocytosis of liposomes by macrophages: Suppressive effects of &stealth& lipids. Biochem. Biophys. Res. Commun. 176:866-874; 1991.
31. Michalek, M.T.; Mold, C.; Bremer, E.C. Inhibition of the alternative pathway of human complement by structural analogues of sialic acid. J. Immunol. 140:1588-1594; 1988.
32. Lee, K.-D.; Hong, K.; Papahadjopoulos, D. Recognition of liposomes by cells: In vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density. Biochem. Biophys. Acta 1103:185-197; 1992.
33. Lutz, H.U. Erythrocyte clearance. In: J.R. Harris (Ed.). Blood Cell Biochemistry. Vol. 1. New York & London: Plenum Press; 1990: pp. 81-120.
34. Bodmer, D.M.; Tiefenauer, L.X.; Andres, R.Y. Antigen-versus antibody immobilized ELISA procedures using a biotin-estradiol conjugate. J. Steroid Biochem. 33:1161-1166; 1989.
35. Tschirky, A.C.; Kühne, G.; Tiefenauer, L. Tumor targeting using antibody nanoparticles modified by sialic acid compounds. In: Book of Abstracts: Third Meeting of the Society of Magnetic Resonance. Nice, France:SMR; 1995: p. 1137.
36. Tiefenauer, L.X.; Andres, R.Y. Complement C4 binds to magnetite nanoparticles and may induce fast blood elimination. In: Book of Abstracts: Second Meeting of the Society of Magnetic Resonance. San Francisco, CA:SMR; 1994: p. 929.
37. Bogdanova, A.; Nossiff, N.; Bogdanov, A.; Brady, T.J.; Weissleder, R. The role of opsonins in cellular uptake of dextran-stabilized superparamagnetic iron oxides. In: Book of Abstracts: Second Meeting of the Society of Magnetic Resonance. San Francisco, CA:SMR; 1994: p. 931.
38. Michalek, M.T.; Bremer, E.G.; Mold, C. Effect of gangliosides on activation of the alternative pathway of human complement. J. Immunol. 140:1581-1587; 1988.
39. Krieg, F.; Andres, R.Y.; Winterhalter, K.H. Superparamagnetically labelled neutrophils as potential abscess-specific contrast agent for MRI. Magn. Reson. Imaging 13:393-400; 1995.
40. Kühne, G.; Fletcher, L.; Hornak, J.; Tiefenauer, L.X.; Andres, R.Y. Superparamagnetic contrast agent visualized by image segmentation. In: Book of Abstracts: Tenth Annual Meeting of the Society of Magnetic Resonance Imaging. New York, NY:SMRI; 1992: p. 405.
41. Tanimoto, A.; Pouliquen, D.; Kreft, B.P.; Stark, D.D. Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide. J. Magn. Reson. Imaging 4:653-657; 1994.
42. Illum, L.; Hunneyball, I.M.; Davis, S.S. The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritonal macrophages. Int. J. Pharmaceutics 29:53-65; 1986.